During the last session, Jaguar Health, Inc. (NASDAQ:JAGX)’s traded shares were 4,903,544, with the beta value of the company hitting 1.57. At the end of the trading day, the stock’s price was $1.87, reflecting an intraday loss of -5.08% or -$0.1. The 52-week high for the JAGX share is $4.47, that puts it down -139.04% from that peak though still a striking +90.11% gain since the share price plummeted to a 52-week low of $0.185. The company’s market capitalization is $239.19 Million, and the average intraday trading volume over the past 10 days was 8.07 Million shares, and the average trade volume was 26.64 Million shares over the past three months.
Jaguar Health, Inc. (JAGX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1. JAGX has a Sell rating from none of the analyst(s) out of 1 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 1 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.1.
Jaguar Health, Inc. (NASDAQ:JAGX): Trading Information
Jaguar Health, Inc. (JAGX) registered a -5.08% downside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.43% in intraday trading to $2.16 this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is 7.47%, and it has moved by 16.87% in 30 days. Based on these gigs, the overall price performance for the year is 129.45%. The short interest in Jaguar Health, Inc. (NASDAQ:JAGX) is 3.94 Million shares and it means that shorts have 0.15 day(s) to cover.
The consensus price target of analysts on Wall Street is $4.5, which implies an increase of 140.64% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.5 and $4.5 respectively. As a result, JAGX is trading at a discount of 140.64% off the target high and 140.64% off the low.
Jaguar Health, Inc. (JAGX) projections and forecasts
Statistics show that Jaguar Health, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Jaguar Health, Inc. (JAGX) shares have gone up +503.23% during the last six months. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 95% this quarter and then jump 94.6% in the quarter after that. In the rating firms’ projections, revenue will increase 62.5% compared to the previous financial year.
Revenue for the current quarter is expected to be $2.58 Million as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $7.37 Million by the end of May 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $1.51 Million and $869Million respectively. In this case, analysts expect current quarter sales to grow by 70.9% and then jump by 748.1% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings fell an estimated 0%. While earnings are projected to return 90.6% in 2021, the next five years will return 40% per annum.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Jaguar Health, Inc. (NASDAQ:JAGX)’s Biggest Investors
Jaguar Health, Inc. insiders own 10.63% of total outstanding shares while institutional holders control 5.71%, with the float percentage being 6.39%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 24 institutions own stock in it. As of Dec 30, 2020, the company held over 1.58 Million shares (or 1.24% of all shares), a total value of $1.29 Million in shares.
The next largest institutional holding, with 427.47 Thousand shares, is of Geode Capital Management, LLC’s that is approximately 0.33% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $348.38 Thousand.
Also, the Mutual Funds coming in first place with the largest holdings of Jaguar Health, Inc. (JAGX) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Dec 30, 2020 indicates that Vanguard Extended Market Index Fund owns about 1,581,583 shares. This amounts to just over 1.24 percent of the company’s overall shares, with a $1.29 Million market value. The same data shows that the other fund manager holds slightly less at 281.65 Thousand, or about 0.22% of the stock, which is worth about $591.46 Thousand.